Jon Hunt - Heartbeam Exec Officer

Heartbeam Management Efficiency

The company has return on total asset (ROA) of (0.6975) % which means that it has lost $0.6975 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1362) %, meaning that it created substantial loss on money invested by shareholders. Heartbeam's management efficiency ratios could be used to measure how well Heartbeam manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.9 in 2024. Return On Capital Employed is likely to gain to -0.91 in 2024. Change To Liabilities is likely to gain to about 1.9 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 16.3 M in 2024.

Similar Executives

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. Heartbeam operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. Heartbeam (BEAT) is traded on NASDAQ Exchange in USA. It is located in 2118 Walsh Avenue, Santa Clara, CA, United States, 95050 and employs 15 people. Heartbeam is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Heartbeam Leadership Team

Heartbeam Stock Performance Indicators

Additional Tools for Heartbeam Stock Analysis